Servier – Phlebolymphology

Dear Readers,

In this new issue of Phlebolymphology, you will find the following articles:

P. PRANDONI (Italy) conveys important considerations regarding the risk of recurrent venous thromboembolism (VTE) after the interruption of anticoagulation, subsequent to an unprovoked or weakly provoked episode of VTE. The author suggests a risk stratification in order to identify those patients in whom anticoagulant therapy can be safely interrupted.

A. N. NICOLAIDES (Cyprus) draws attention to a frequent pathology: isolated deep venous thrombosis (DVT) of the calf. In these cases, routine anticoagulant therapy is controversial. The analysis of randomized clinical trials provides us with a clear indication for treatment with direct oral anticoagulants (DOACs).

The current possibility of recanalizing an iliocaval obstruction with a venoplasty-stenting technique is illustrated by M. LUGLI (Italy) who underlines the importance of carefully selecting patients to undergo this procedure. Deep vein obstruction is a primary cause of severe chronic venous insufficiency and impaired quality of life, especially in young patients affected by postthrombotic syndrome. Besides medical and compression therapies, which undoubtedly still represent the standard of care, an operative approach in selected cases should be considered today. Venoplasty and stenting for deep vein recanalization of the iliocaval segment have demonstrated efficacy, leading to satisfactory results with a low complication rate, thus suggesting an increasingly broad approach to this treatment.


Enjoy reading this issue!

Editor in chief
Dr Oscar Maleti